The Devil’s in the Regulations Impact on Product Testing May 18, 2009 Richard G. Higby President / Managing Director.

Slides:



Advertisements
Similar presentations
EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance.
Advertisements

An Introduction to Quality Assurance in Analytical Science
Next steps for the regulation of cigarettes Bill King and Ron Borland.
Menthol and Tobacco Regulation
ADDITIONAL TESTS Ignition Propensity Testing Toxicity Assays.
Information on tobacco packages could encourage and help tobacco users to stop using tobacco or find least possible harmful ways of use for those unable.
Patricia Richter Ph.D., DABT Centers for Disease Control and Prevention Office on Smoking and Health Tobacco Product Constituents Subcommittee June 8-9,
MFRPS 10 Laboratory Support: Relationship to the Sampling Agreement Requirement Steven M. Sobek Director - Bureau of Laboratory Services State of Wisconsin.
TM Clifford Watson, Ph.D. Centers for Disease Control and Prevention National Centers for Environmental Health Division of Laboratory Sciences June 8-9,
FDA Tobacco Regulations. During the 90’s  1998 Master Settlement Agreement  Tobacco companies charged.
Good Laboratory Practice (GLP)
Food Safety Systems in some Member States of the European Union Dieter Arnold Berlin Dieter Arnold
 2011 Johns Hopkins Bloomberg School of Public Health Regulation of Tobacco Products Mitch Zeller, JD Pinney Associates.
Richard G. Higby, Ph.D. President Arista Laboratories, Inc.
THE SUNRISE PROCESS IN ARIZONA. SUNSET REVIEWS Requires periodic audits and legislative review and reauthorization of state agencies to determine if “the.
Good Laboratory Practices (GLPs)
1 Questions to the Subcommittee 1.What criteria do you recommend to TPSAC for selecting the initial list of H/PH constituents?
Kenneth E. Warner University of Michigan University of Iowa November 15, 2002 Technology, Policy, and the Future of Nicotine Addiction.
Do Electronic Cigarettes Correlate with Cancer?
FDA’s Center for Tobacco Products Overview of FDA’s Authority and Current Enforcement Activities July 25, 2012.
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Staffing and Training.
HOKLAS th Edition HOKLAS 003 Technical Criteria for Laboratory Accreditation 8 th Edition October 2005.
GLP & Quality Assurance
What is the GLP?.
WHY CONFORMITY ASSESSMENT?. What is conformity assessment?  Conformity assessment is the name given to processes that are used to demonstrate that a.
Overview of existing assessment schemes Rolf Bienert, John Lin.
John Neuner, Program Manager ASCLD/LAB-International CWAG January 28, 2010 Sacramento, California.
Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958 (FFDCA) Katie Buhai Period 3.
LEADERSHIP FLY-IN Washington, D.C. June 26-28, 2012 US GAPP LEADERSHIP FLY-IN Washington, D.C. June 26-28, 2012 US GAPP.
It’s time to Stop Big Tobacco … … and we need your help.
 2011 Johns Hopkins Bloomberg School of Public Health Building Blocks for Effective Tobacco Product Regulation Section B.
Presented by Steven P. Feltman Food Safety and Quality Specialist.
Regulatory Primer 101 Patrick Kennelly, Chief Food Safety Section California Department of Public Health March 11, 2014.
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Laboratory Accreditation as a Component of the Help America Vote Act Mary H. Saunders Chief, Standards Services Division.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
Latham & Watkins operates as a limited liability partnership worldwide with affiliated limited liability partnerships conducting the practice in the United.
NSF International Overview. NSF International Established in 1944, as the National Sanitation Foundation, (University of Michigan Professors), a standards.
 2007 Johns Hopkins Bloomberg School of Public Health Regulation of Tobacco Products Mitch Zeller, JD Pinney Associates.
Towards an Industry Advisory Group An Open Round-Table Conversation 19 May 2009 Do not copy or reproduce without express written permission of Foresight.
Norris Cotton Cancer CenterJames Sargent MD Professor of Pediatrics Geisel School of Medicine at Dartmouth James Sargent MD Professor of Pediatrics Geisel.
Cutting tobacco’s death toll − an overview of different options Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 5th Annual Conference.
International Atomic Energy Agency Roles and responsibilities for development of disposal facilities Phil Metcalf Workshop on Strategy and Methodologies.
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
Overview of Drugs and Biologics Dr Léo Bouthillier, Therapeutic Products Directorate & Dr Omar Tounekti, Biologics and Genetic Therapies Directorate Health.
FDA Regulation: The Impact on Product Development and Reporting Monica Graves Director – Marketing Operations Oversight RAI Services Company May 18, 2009.
November 19, Stacy Ehrlich, Esq. Partner Kleinfeld Kaplan & Becker LLP Washington, DC
CGMPs BT 202 Biotechnology Techniques II. Food and Drug Administration Established under 1906 Pure Food and Drugs Act to prevent sale of unacceptable.
Medical Device Regulations in Canada; Key Challenges and International Initiatives.
Conformity Assessment Requirements to Access the U.S. Market - An Overview - Steven Bipes Program Manager – Regional & Bilateral Policy.
TAIEX Workshop on the Accreditation of Medical and Clinical Laboratories (55902) “ROLE AND VALUE OF THE MEDICAL LABORATORIES ACCREDITATION” Aliki Stathopoulou.
Establishment of Medical Device GMP Requirements Hsiau-Wen Huang, Ph. D. Senior Researcher Bureau of Pharmaceutical Affairs Department of Health.
Regulation of Generic Animal Drugs in the United States
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
Strategies for regulation of cigarette emissions The WHO product regulatory approach Nigel Gray David Burns For TobReg Working Group 1 in Conjunction with.
INVESTIGATION TASK CIGARETTE CHANGES BY JESS M AND JESS D NO SMOKING PAST THIS POINT!!!!!
Regulation of: - amounts of various constituents in cigarette smoke - information on packages regarding smoke constituents - smokefree tobacco products.
Principles of Good Laboratory Practice and Reliability Requirements
TOBACCO POLICIES & LAWS
OUS Data: What does the CE Mark Really Mean?
ACCREDITATION PROCESS
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
RDLA's July Legislative Webinar
OECD Principles of GLP and Test Guidelines
Health Consequence of Smoking. Part I
آشنایی با سیگار.
Patient Involvement in the Development and Safe Use of
Presentation transcript:

The Devil’s in the Regulations Impact on Product Testing May 18, 2009 Richard G. Higby President / Managing Director

 An independent, ISO 17025:2005 accredited laboratory (A2LA, UKAS) specializing in the characterization of tobacco and tobacco smoke  Locations: Richmond, VA; Kingston upon Thames  Founded: April 2000  Ownership: Molins PLC

Pick any two…

 Annual registration of products  Testing requirements (passage + 24 months)  Data submission (passage + 36 months)

 Ingredients  Tar, nicotine yield  Smoke constituents ◦ Mainstream ◦ Side stream  Tobacco constituents  All brands

 “Brand” distinguished by: ◦ Tobacco (blend) ◦ Tar content (yield) ◦ Nicotine content (yield) ◦ Flavor (menthol, non-characterizing flavor) ◦ Size (King, 100, slim, etc.) ◦ Filtration (non-filter, charcoal) Every stick and blend variant manufactured is a “brand”

Smoke Constituents Blend A Kings Full flavor RegularLights Ultra Lights Full flavor MentholLights Ultra Lights 100s Full flavor RegularLights Ultra Lights Menthol Full flavor Lights Ultra Lights ABC Tobacco  Blend B Kings Regular Full flavor Lights Ultra Lights Menthol Full flavor Lights Ultra Lights 100s Regular Full flavor Lights Ultra Lights Menthol Full flavor Lights Ultra Lights Total12

 Health Canada  ANVISA – Brazil  WHO –TFI ◦ Framework Convention on Tobacco Control ◦ TobReg ◦ TobLabNet

Health Canada/ANVISATobReg  Ammonia  Aromatic amines (4)  Benzo[a]pyrene  Carbonyls (9)  Eugenol  Hydrogen cyanide  Mercury  Metals (6)  Nitrosamines (4)  NOx  Organics (5)  Phenolics (7)  Semivolatiles (3)  Tar, nicotine, CO  Aromatic amines (2)  Benzo[a]pyrene  Carbonyls (3)  Hydrogen cyanide  Mercury  Metals (6)  Nitrosamines (4)  NOx  Benzene  1,3-butadiene  Ethylene oxide  Tar, Nicotine/free nicotine, CO

Health Canada/ANVISATobReg  Ammonia  Aromatic amines (4)  Benzo[a]pyrene  Carbon monoxide  Carbonyls (9)  Hydrogen cyanide  Mercury  Metals (6)  Nitrosamines (4)  NOx  Organics (5)  Phenolics (7)  Semivolatiles (3)  Tar and nicotine

Health Canada/ANVISATobReg  Alkaloids (5)  Ammonia  Benzo[a]pyrene  Eugenol  Humectants (3)  Metals (7)  Nitrate  Nitrosamines (4)  pH  Propionate  Sorbic acid  Triacetin

 FTC Smoking (35/60/2; 24h conditioning)  ISO Smoking (35/60/2; 48h conditioning)  “Canadian” Intense Smoking (45/30/2; 100% vent blocking)  “Massachusetts” smoking (45/30/2; 50% vent blocking)  Other methods yet to be defined

Health Canada/ANVISATobReg  Smoke constituents ◦ Mainstream methods (14) ◦ Mainstream constituents (47) ◦ Side stream methods (14) ◦ Side stream constituents (45)  Tobacco constituents ◦ Methods (12) ◦ Constituents (27)  Smoking regimes (2) Total Methods (40) Total Endpoints (121)  Smoke constituents ◦ Mainstream methods (10) ◦ Mainstream constituents (24)

 Health Canada ◦ In vitro assays are required to measure:  Cytotoxicity (neutral red uptake assay)  Mutagenicity (Ames Salmonella assay)  Genotoxicity (micronucleus)  Family Smoking Prevention and Tobacco Control Act ◦ Toxicology is mentioned in terms of reduced harm products

 ISO 17025:2005 ◦ Laboratories are accredited in accordance with the recognized International Standard ISO/IEC 17025:2005 General Requirements for the Competence of Testing and calibration Laboratories. This accreditation demonstrates technical competence for a defined scope and the operation of a laboratory quality management system (refer to joint ISO-ILAC-IAF Communiqué dated 18 June 2005).  Good Laboratory Practices (GLP) ◦ Good Laboratory Practice (GLP) embodies a set of principles that provides a framework within which laboratory studies are planned, performed, monitored, recorded, reported and archived. These studies are undertaken to generate data by which the hazards and risks to users, consumers and third parties, including the environment, can be assessed for pharmaceuticals (only preclinical studies), agrochemicals, cosmetics, food additives, feed additives and contaminants, novel foods, biocides, detergents etc.... GLP helps assure regulatory authorities that the data submitted are a true reflection of the results obtained during the study and can therefore be relied upon when making risk/safety assessments.

 ISO 17025:2005 ◦ 22 quality procedures  Good Laboratory Practices ◦ 104 standard operating procedures

 United States Lobbying activity surrounding the bill to grant the US Food and Drug Administration regulatory control over tobacco products, which passed the House in a vote on April 2nd and will be taken up by the Senate Health, Education, Labor and Pensions HELP Committee this week, was intense in the first quarter of 2009, with Altria, the lone industry player to support the measure, spending $4.29 million on the FDA bill and a couple of other pieces of tobacco legislation, while rivals Reynolds American and Lorillard paid lobbyists $1.59 million and $850,000, respectively, in that period, according to Federal lobbying records. (Washington Post 05/11)

 Clinical use trials ◦ E.g. 100 smokers with puff profiling  Toxicology ◦ In vitro assays  Cytotoxicity  Neutral red uptake assay  Clastogenicity  Micronucleus, sister chromatid exchange  Mutagenicity  Ames Salmonella assay ◦ Other assays  Inflammation